CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $697,937
- in 4 filings, $698K under 10b5-1 plans
Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-03 | MITCHELL PAUL J Director | Exercise or conversion · Non Qualified Stock Option (Right to Buy) | −1,000 | 11,000 | ||
| 2018-11-02 | MITCHELL PAUL J Director | Exercise or conversion | +1,000 | $8.98 | $9K | 1,000 |
| 2018-11-02 | MITCHELL PAUL J Director | Sale | −1,000 | $37.51 | $38K | 0 |
| 2018-11-02 | MITCHELL PAUL J Director | Exercise or conversion · Non Qualified Stock Option (Right to Buy) | −1,000 | 12,000 | ||
| 2018-10-01 | MITCHELL PAUL J Director | Exercise or conversion | +1,000 | $8.98 | $9K | 1,000 |
| 2018-10-01 | MITCHELL PAUL J Director | Sale | −1,000 | $42.42 | $42K | 0 |
| 2018-10-01 | MITCHELL PAUL J Director | Exercise or conversion · Non Qualified Stock Option (Right to Buy) | −1,000 | 13,000 | ||
| 2018-09-04 | MITCHELL PAUL J Director | Exercise or conversion | +1,000 | $8.98 | $9K | 1,000 |
| 2018-09-04 | MITCHELL PAUL J Director | Sale | −1,000 | $44.58 | $45K | 0 |
| 2018-09-04 | MITCHELL PAUL J Director | Exercise or conversion · Non Qualified Stock Option (Right to Buy) | −1,000 | 14,000 | ||
| 2018-08-01 | MITCHELL PAUL J Director | Exercise or conversion | +1,000 | $8.98 | $9K | 1,000 |
| 2018-08-01 | MITCHELL PAUL J Director | Sale | −1,000 | $43.68 | $44K | 0 |
| 2018-08-01 | MITCHELL PAUL J Director | Exercise or conversion · Non Qualified Stock Option (Right to Buy) | −1,000 | 15,000 | ||
| 2018-07-16 | BLOOM FLOYD E Director | Sale | −20,000 | $43.95 | $879K | 127,923 |
| 2018-07-03 | MITCHELL PAUL J Director | Exercise or conversion | +1,000 | $8.98 | $9K | 1,000 |
| 2018-07-03 | MITCHELL PAUL J Director | Sale | −1,000 | $41.86 | $42K | 0 |
| 2018-07-03 | MITCHELL PAUL J Director | Exercise or conversion · Non Qualified Stock Option (Right to Buy) | −1,000 | 16,000 | ||
| 2018-06-12 | FRATES JAMES M SVP, Alks Inc; CFO ALKS | Sale | −16,842 | $50.00 | $842K | 37,234 |
| 2018-06-07 | Hopkinson Craig C. SVP, Med Dev/Med Affairs, CMO | Exercise or conversion | +1,250 | 1,250 | ||
| 2018-06-07 | Hopkinson Craig C. SVP, Med Dev/Med Affairs, CMO | Shares withheld for taxes | −369 | $48.30 | $18K | 881 |
Page 88 of 90 · 1,796 trades